Molecular Diagnostic Solutions
With the potential to ease the burden of disease in Australia, the evolving diagnostics industry is facilitating a shift from managing chronic diseases as they arise to detecting them well before they’ve had a chance to take hold. We’re contributing to this rapidly expanding industry by developing innovative solutions that can detect chronic diseases like cancer, Alzheimer’s disease and metabolic diseases earlier.
Designing consumer-friendly technologies for early detection is crucial to disease management. Our scope includes:
- Delivering solutions for management of major diseases (e.g. ColveraTM and ColoSTATTM for early colorectal cancer detection).
- Developing novel models of human disease for drug and bioactive testing.
- Uncovering new biomarkers through proteomic, genomic and epigenetic screening.
- Development of non-invasive and cost-effective tests